Načítá se...
Contrasting effect of recombinant human erythropoietin on breast cancer cell response to cisplatin induced cytotoxicity
BACKGROUND: Human recombinant erythropoietin (rHuEpo) that is used for the treatment of the chemotherapy-induced anaemia in cancer patients was shown to cause detrimental effects on the course of disease due to increased adverse events inflicting patient’s survival, potentially related to rHuEpo-ind...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Versita, Warsaw
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3472952/ https://ncbi.nlm.nih.gov/pubmed/23077460 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/v10019-012-0037-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|